Information Request Form

Please enter your message in the form below. Your message will be emailed directly to the contact associated with the press release upon the submission of the form.

Press Release:
Can-Fite BioPharma's CF101 Drug Selected as one of the "Top Autoimmune/Anti-Inflammatory Disease Projects to Watch" by Elsevier Business Intelligence
Press Release Date:
10/15/2013 07:00 AM Eastern Time
Your Email Address: (Required)
Subject Line: (Required)
Your Name:
Your Title:
Your Company/Publication Name:
Your Message: (Required)

Information entered into this form will be relayed, solely to the Marketwire client contact that is associated with this release. Your privacy is important to us, and we make sure it is properly protected. Please see our privacy policy for more details.